article thumbnail

What Happened to the COVID-19 Vaccine Patent Waiver?

Bill of Health

In June 2022, after almost two years of debate over a potential COVID-19 vaccine patent waiver, the World Trade Organization adopted the Ministerial Decision on the TRIPS Agreement (“WTO Decision”), which provided for a partial waiver of intellectual property rights. By Sarah Gabriele. appeared first on Bill of Health.

article thumbnail

COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues

Bill of Health

In October 2020, Moderna pledged not to enforce its patents amid the ongoing pandemic. government committed more than one billion dollars to Moderna for development of its COVID-19 vaccines. Moderna has since made over $30 billion in COVID-19 vaccine sales. Indeed, as made public, the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

UPS Launches First COVID-19 Vaccine Drone Deliveries at Atrium Health Wake Forest

HIT Consultant

What You Should Know: – UPS, together with its UPS Flight Forward (UPSFF) subsidiary, announced it is now making COVID-19 vaccine deliveries via drone for Atrium Health Wake Forest Baptist in Winston-Salem, North Carolina, using new cold chain packaging developed specifically for drones. Drone with UPS Flight Forward.

article thumbnail

Judging in the Pandemic – A Malawian Perspective

Bill of Health

Kathumba case: separation of powers, social security, and lockdowns The Khatumba case involved an order made by the Minister of Health for a temporary, national 3-week lockdown from April 18, 2020 to May 2020 due an increase in COVID-19 cases.

COVID-19 302
article thumbnail

One Medical addresses COVID-19 vaccine allegations during Q4 2020 earnings call

Mobi Health News

Outside of the claims, One Medical’s financial results for both the fourth quarter and full year of 2020 improved year-over-year. .

article thumbnail

Will NIH Learn from Myriad when Settling Its mRNA Inventorship Dispute with Moderna?

Bill of Health

The National Institutes of Health (NIH) is currently embroiled in a dispute over the ownership of patent rights to Moderna’s flagship mRNA COVID-19 vaccine (mRNA-1273). If so, NIH, their employer, would be a co-owner of the vaccine technology and could, in theory, make it more broadly available around the world.

article thumbnail

COVID-19, Patents, and Trade Secrets

Bill of Health

Has the worldwide distribution of COVID-19 vaccines been impacted by patent rights? Tran , senior associate at Milbank LA, argue that the story is much more complicated — making vaccines involves much more than waiving patents, they explain. It’s been quite a remarkable journey from March 2020 when everything shut down.

COVID-19 291